Northern Trust’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
89,279
-75,177
-46% -$213K ﹤0.01% 3842
2026
Q1
$398K Buy
164,456
+21,618
+15% +$58.9K ﹤0.01% 3697
2025
Q4
$623K Buy
142,838
+11,536
+9% +$62.3K ﹤0.01% 3578
2025
Q3
$551K Buy
131,302
+64,887
+98% +$230K ﹤0.01% 3617
2025
Q2
$191K Buy
66,415
+10,516
+19% +$27.8K ﹤0.01% 3954
2025
Q1
$151K Buy
55,899
+8,989
+19% +$33.7K ﹤0.01% 4019
2024
Q4
$111K Sell
46,910
-806
-2% -$2.14K ﹤0.01% 4135
2024
Q3
$113K Sell
47,716
-97,589
-67% -$215K ﹤0.01% 4021
2024
Q2
$283K Sell
145,305
-17,180
-11% -$58.4K ﹤0.01% 3725
2024
Q1
$1.04M Sell
162,485
-1,598
-1% -$14.5K ﹤0.01% 3289
2023
Q4
$2.3M Buy
164,083
+3,267
+2% +$51.6K ﹤0.01% 2919
2023
Q3
$3.94M Buy
160,816
+128,079
+391% +$3.25M ﹤0.01% 2583
2023
Q2
$1.07M Buy
32,737
+21,552
+193% +$606K ﹤0.01% 3334
2023
Q1
$310K Buy
+11,185
New +$181K ﹤0.01% 3657

Other funds holding GNLX

Northern Trust's GNLX Position: Q2 2026 in Review

Northern Trust reduced its Genelux (GNLX) stake by 46% in Q2 2026, selling an estimated $213K and leaving 89,279 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

Northern Trust first reported a position in GNLX in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.94M in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Northern Trust held 89,279 shares of Genelux worth $269K as of Q2 2026.
  • Northern Trust sold 75,177 Genelux shares in Q2 2026, an estimated $213K.
  • Genelux made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3842 holding.
  • Northern Trust first reported a position in Genelux in Q1 2023 and has held it in 14 quarters since.
  • Northern Trust's Genelux position peaked at $3.94M in Q3 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.